Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Effects of SGLT2i on Kidney Allograft Oxygenation
NCT06933355Phase 4Active, not recruiting
- Sponsor
- University Hospital Odense
- Start
- Mar 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of empagliflozin in kidney transplantation, sponsored by University Hospital Odense. Started Mar 2025; status: active, not recruiting.
02
Drugs
empagliflozin
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT06933355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06933355.